Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

Clinical trial NCT02259725 · COMPLETED

Trial details

NCT number: NCT02259725
Sponsor: University of Southern California
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrinoma Glucagonoma Insulinoma Metastatic Gastrointestinal Carcinoid Tumor Pancreatic Polypeptide Tumor Pulmonary Carcinoid Tumor Recurrent Gastrointestinal Carcinoid Tumor Recurrent Islet Cell Carcinoma Somatostatinoma

Start date: 2016-08-16
Primary completion: 2020-08-20
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.